Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Natera Inc NTRA

Healthcare Medical Care
Natera, Inc. provides cell-free DNA (cfDNA) and genetic testing, dedicated to oncology, women’s health, and organ health. The Company's cfDNA technology platform combines novel molecular biology techniques with bioinformatics software and artificial intelligence. It has leveraged its platform to develop non-invasive prenatal test on the market (Panorama), the first tumor-specific assay for... see more

Current News (NDAQ:NTRA)

Natera Integrates with Flatiron Health's OncoEMR® Platform

Business Wire 4 days ago

Natera Reports Third Quarter 2025 Financial Results

Business Wire 9 days ago

Natera Announces Expansion to 20 Genes for its Fetal Focus(TM) Single-Gene NIPT

Business Wire October 31, 2025

Natera to Report its Third Quarter Results on November 6, 2025

Business Wire October 30, 2025

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Business Wire October 28, 2025

Halper Sadeh LLC Encourages Natera Inc. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire October 27, 2025

Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients

Business Wire October 20, 2025

Natera Named to Fast Company's Next Big Things in Tech List

Business Wire October 16, 2025

Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings

Business Wire October 13, 2025
View More News ››

Opinion & Analysis (NDAQ:NTRA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NTRA)

Be the first to post on this bullboard.

LaFleur Minerals Inc.

LaFleur Minerals Inc.

LaFleur Minerals Inc. is focused on the development of district-scale gold projects in the Abitibi Gold Belt near Val-d'Or ...
View More »